EUVIMEDEUVIMED entdecken
Crossref

L26/O-214 Everolimus preserves xenotransplanted human ovarian tissue by inhibiting primordial follicle activation via the mTOR/S6/eIF4B signaling pathway

Y. Kuang, Y. Guan, R. Shen, J. Han, N. Meng, Y. Liu, X. Yuan, W. Zheng, C. Yang, R. Zu

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Kuang und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can pharmacological inhibition of mTOR pathway via everolimus preserve the primordial follicle pool and enhance graft survival in xenotransplanted human ovarian cortical tissues after cryopreservation? Summary answer Everolimus effectively suppresses primordial follicle activation and expression of mTOR signaling pathway in human ovarian tissues, preserving the dormant follicle reserve and enhancing graft longevity What is known already Excessive follicular activation following ovarian tissue transplantation accelerates primordial follicle depletion, compromising graft longevity and reproductive endocrine function. The mTOR signaling pathway is a key regulator of follicular activation, but its inhibition in xenotransplanted human ovarian tissue remains unexplored. Study design, size, duration Pieces of frozen-thawed human ovarian tissue from 6 women aged 25–34 years were transplanted beneath the bilateral renal capsules of 8-week-old female Severe Combined Immunodeficiency mice. In the experimental group, mice received an intraperitoneal injection of everolimus at a dose of 2.5 mg/kg/d within 14 days post-transplantation (n = 10 mice per group). The control group was administered an equal volume of normal saline via intraperitoneal injection based on body weight. Participants/materials, setting, methods After vitrification and thawing, cortical fragments were transplanted beneath renal capsules of SCID mice, followed by intraperitoneal injection of everolimus or normal saline. Fourteen days later, the grafts were retrieved, and number of follicles was evaluated. Gene expression analysis of mTOR signaling pathway by measuring mRNA expression levels. Grafts retrieved were subjected to histological processing. Follicle counting was performed via HE staining, fibrosis was analyzed using Masson staining, mTOR phosphorylated proteins were evaluated by immunohistochemistry. Main results and the role of chance In vivo experiments show that at 14 days post-transplantation, compared with the control group, the relative expression of p-mTOR, p-S6, and p-eIF4B was significantly reduced in the everolimus-treated group (P < 0.01, P < 0.001, and P < 0.001, respectively). Additionally, the serum anti-Müllerian hormone (AMH) levels in mice from the everolimus-treated group (5072.38±239.42 pg/mL) were significantly lower than those in the control group (5986.26±437.333 pg/mL)( P <0.0001). However, the proportion of primordial follicles in the ovarian cortex was significantly higher in the everolimus-treated group (P < 0.01). Furthermore, this inhibitory effect was recapitulated in vitro, where it was found to suppresses the proliferation (P < 0.0001) and migration (P <0.001) of human ovarian granulosa KGN cells by targeting the mTOR/S6/eIF4B signaling cascade. Compared with the control group, the mRNA expression levels of mTOR and S6 in everolimus-treated KGN cells were significantly decreased in the experimental group (P < 0.05). Moreover, the phosphorylation levels of proteins, including p-mTOR, p-eIF4B, and p-S6, were significantly reduced in everolimus-treated KGN cells (P < 0.001). Limitations, reasons for caution The study used an immunodeficient mouse model, which not fully mimic human physiology. Retrieved xenotransplanted ovarian tissue fragments were not subjected to gravimetric analysis; however, quantitative assessment of weight changes would provide a more direct and objective measure of drug-induced effects. Long-term endocrine function and fertility restoration were not assessed. Wider implications of the findings Everolimus-mediated mTOR inhibition offers a clinically translatable approach to extend ovarian graft survival by preventing follicular activation. This strategy could enhance fertility preservation and hormone restoration outcomes in patients undergoing ovarian tissue transplantation. Trial registration number No

Zitieren

APA

Kuang, Y., Guan, Y., Shen, R., Han, J., Meng, N., Liu, Y., Yuan, X., Zheng, W., Yang, C., & Zu, R. (2026). L26/O-214 Everolimus preserves xenotransplanted human ovarian tissue by inhibiting primordial follicle activation via the mTOR/S6/eIF4B signaling pathway. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.212

Vancouver

Kuang Y, Guan Y, Shen R, Han J, Meng N, Liu Y, et al. L26/O-214 Everolimus preserves xenotransplanted human ovarian tissue by inhibiting primordial follicle activation via the mTOR/S6/eIF4B signaling pathway. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.212

BibTeX
@article{Kuang2026,
  author = {Kuang, Y. and Guan, Y. and Shen, R. and Han, J. and Meng, N. and Liu, Y. and Yuan, X. and Zheng, W. and Yang, C. and Zu, R.},
  title = {L26/O-214 Everolimus preserves xenotransplanted human ovarian tissue by inhibiting primordial follicle activation via the mTOR/S6/eIF4B signaling pathway},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.212}
}
Kostenlos starten →